BofA Securities Starts Amphastar Pharmaceuticals (AMPH) at Neutral
Tweet
Share
E-mailGet Alerts AMPH Hot Sheet
Price: $20.18 --0%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 8
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 13 | New: 8
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry initiates coverage on Amphastar Pharmaceuticals (NASDAQ: AMPH) with a Neutral rating and a price target of $63.00.
For an analyst ratings summary and ratings history on Amphastar Pharmaceuticals click here. For more ratings news on Amphastar Pharmaceuticals click here.
Shares of Amphastar Pharmaceuticals closed at $56.17 yesterday.
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- Goldman Sachs Starts Vail Resorts (MTN) at Sell
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
